Overview

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

Status:
Withdrawn
Trial end date:
2009-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the treatment of skin growths called actinic keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other conventionally used FDA-approved agents such as cryotherapy, Imiquimod, or 5-fluorouracil (5-FU).
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Chicago
Treatments:
Aminolevulinic Acid
Imiquimod
Criteria
Inclusion Criteria:

- 18-95 years old

- Diagnosied with actinic keratoses.

Exclusion Criteria:

- Patients who have had Isotretinoin therapy less that 1 year prior to screening.

- Patients who have an adverse reaction to light exposure (for example photo-
exacerbated seizures).

- History of porphyria